Biovail Financial Market Data
| Last Close 02-Oct-2008 |
$9.56 |
Price/ Sales Ratio |
2.00 |
| 52-Week High |
$20.06 |
Price/ Book Ratio |
1.30 |
| 52-Week Low |
$9.27 |
Price/ Earnings Ratio |
8.58 |
| 60-Month Beta |
1.1 |
Price/ Cash Flow Ratio |
4.95 |
| Market Cap (mil.) |
-- |
Return on Assets |
9.8% |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
15.0% |
| Dividend Rate |
1.50 |
Current Ratio |
1.92 |
| Dividend Yield |
150.0% |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
180 |
% Owned by Institutions |
60.0% |
| Latest Short Interest Ratio |
2.19 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
(21.1%) |
(4.9%) |
7.0% |
| EPS Growth |
(7.6%) |
20.8% |
110.3% |
| Dividend Growth |
(14.3%) |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
